Kyzer 1995.
Study characteristics | ||
Methods | Parallel, 24 h | |
Participants | PCA 12, control 11 Gastroplasty (1 participant in each group also had cholecystectomy) | |
Interventions | PCA: morphine. Bolus/lockout/4 h limit: 2 mg/15 min/NR Control: IM meperidine (converted to morphine equivalents) 50 mg to 100 mg every 3 to 4 h prn |
|
Outcomes | Pain intensity, opioid consumption, sedation, respiratory rate, blood gas levels, LOS, duration of ileus, incidence of pruritus/nausea/vomiting/complications | |
Source of funding | Not reported | |
Notes | SAE: wound infections requiring increased length of hospitalization (n), PCA 4 vs control 1 QS = 2 (R = 1, DB = 0, W = 1) |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Not described |
Allocation concealment (selection bias) | Unclear risk | Not mentioned |
Blinding of participants and personnel (performance bias) All outcomes | High risk | Not explicitly stated, but appears to be unblinded |
Incomplete outcome data (attrition bias) All outcomes | Low risk | Not explicitly stated, but appears that all participants completed study |
Selective reporting (reporting bias) | Unclear risk | All outcomes described in Methods section are reported in Results section. Adverse event outcomes mostly presented only as not significantly different between groups |
Other bias | High risk | Very small sample size |